Shiyu Tang, Sung Won Kim, Amanda Olsen-Dufour, Torben Pearson, Michael Freaney, Erick Singley, Madeline Jenkins, Nathaniel J Burkard, Aaron Wozniak, Paul Parcon, Shawn Wu, Cheryl L Morse, Susovan Jana, Jeih-San Liow, Sami S Zoghbi, Janaina C M Vendruscolo, Leandro F Vendruscolo, Victor W Pike, George F Koob, Nora D Volkow, Robert B Innis
The cyclic adenosine monophosphate (cAMP) cascade is thought to play an important role in regulating alcohol-dependent behaviors, with potentially opposite effects following acute versus chronic administration. Phosphodiesterase 4 (PDE4) is the primary brain enzyme that metabolizes cAMP, thereby terminating its signal. Radioligand binding to PDE4 serves as an indirect biomarker of cAMP activity, as cAMP-protein kinase A (PKA)-mediated phosphorylation of PDE4 increases its affinity for radioligand binding ~10-fold...
September 16, 2024: Neuropsychopharmacology